Literature DB >> 22718834

Characterization in vitro and in vivo of pandemic (H1N1) 2009 influenza viruses isolated from patients.

Tokiko Watanabe1, Masaki Imai, Shinji Watanabe, Kyoko Shinya, Masato Hatta, Chengjun Li, Gabriele Neumann, Makoto Ozawa, Anthony Hanson, Gongxun Zhong, Satoshi Fukuyama, Eiryo Kawakami, Heather A Simmons, Daniel Schenkman, Kevin Brunner, Saverio V Capuano, Jason T Weinfurter, Anette Kilander, Susanne G Dudman, M Suresh, Olav Hungnes, Thomas C Friedrich, Yoshihiro Kawaoka.   

Abstract

The first influenza pandemic of the 21st century was caused by novel H1N1 viruses that emerged in early 2009. Molecular evolutionary analyses of the 2009 pandemic influenza A H1N1 [A(H1N1)pdm09] virus revealed two major clusters, cluster I and cluster II. Although the pathogenicity of viruses belonging to cluster I, which became extinct by the end of 2009, has been examined in a nonhuman primate model, the pathogenic potential of viruses belonging to cluster II, which has spread more widely in the world, has not been studied in this animal model. Here, we characterized two Norwegian isolates belonging to cluster II, namely, A/Norway/3568/2009 (Norway3568) and A/Norway/3487-2/2009 (Norway3487), which caused distinct clinical symptoms, despite their genetic similarity. We observed more efficient replication in cultured cells and delayed virus clearance from ferret respiratory organs for Norway3487 virus, which was isolated from a severe case, compared with the efficiency of replication and time of clearance of Norway3568 virus, which was isolated from a mild case. Moreover, Norway3487 virus to some extent caused more severe lung damage in nonhuman primates than did Norway3568 virus. Our data suggest that the distinct replicative and pathogenic potentials of these two viruses may result from differences in their biological properties (e.g., the receptor-binding specificity of hemagglutinin and viral polymerase activity).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22718834      PMCID: PMC3416174          DOI: 10.1128/JVI.01214-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Molecular basis of replication of duck H5N1 influenza viruses in a mammalian mouse model.

Authors:  Zejun Li; Hualan Chen; Peirong Jiao; Guohua Deng; Guobin Tian; Yanbing Li; Erich Hoffmann; Robert G Webster; Yumiko Matsuoka; Kangzhen Yu
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

2.  Printed covalent glycan array for ligand profiling of diverse glycan binding proteins.

Authors:  Ola Blixt; Steve Head; Tony Mondala; Christopher Scanlan; Margaret E Huflejt; Richard Alvarez; Marian C Bryan; Fabio Fazio; Daniel Calarese; James Stevens; Nahid Razi; David J Stevens; John J Skehel; Irma van Die; Dennis R Burton; Ian A Wilson; Richard Cummings; Nicolai Bovin; Chi-Huey Wong; James C Paulson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-24       Impact factor: 11.205

3.  Altered receptor specificity and cell tropism of D222G hemagglutinin mutants isolated from fatal cases of pandemic A(H1N1) 2009 influenza virus.

Authors:  Yan Liu; Robert A Childs; Tatyana Matrosovich; Stephen Wharton; Angelina S Palma; Wengang Chai; Rodney Daniels; Victoria Gregory; Jennifer Uhlendorff; Makoto Kiso; Hans-Dieter Klenk; Alan Hay; Ten Feizi; Mikhail Matrosovich
Journal:  J Virol       Date:  2010-09-08       Impact factor: 5.103

4.  Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic.

Authors:  Gavin J D Smith; Dhanasekaran Vijaykrishna; Justin Bahl; Samantha J Lycett; Michael Worobey; Oliver G Pybus; Siu Kit Ma; Chung Lam Cheung; Jayna Raghwani; Samir Bhatt; J S Malik Peiris; Yi Guan; Andrew Rambaut
Journal:  Nature       Date:  2009-06-25       Impact factor: 49.962

5.  Structure and Receptor binding properties of a pandemic H1N1 virus hemagglutinin.

Authors:  Hua Yang; Paul Carney; James Stevens
Journal:  PLoS Curr       Date:  2010-03-22

Review 6.  Vascular endothelial growth factor and related molecules in acute lung injury.

Authors:  Marco Mura; Claudia C dos Santos; Duncan Stewart; Mingyao Liu
Journal:  J Appl Physiol (1985)       Date:  2004-11

7.  Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus.

Authors:  Carole R Baskin; Helle Bielefeldt-Ohmann; Terrence M Tumpey; Patrick J Sabourin; James P Long; Adolfo García-Sastre; Airn-E Tolnay; Randy Albrecht; John A Pyles; Pam H Olson; Lauri D Aicher; Elizabeth R Rosenzweig; Kaja Murali-Krishna; Edward A Clark; Mark S Kotur; Jamie L Fornek; Sean Proll; Robert E Palermo; Carol L Sabourin; Michael G Katze
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-13       Impact factor: 11.205

8.  A new influenza virus virulence determinant: the NS1 protein four C-terminal residues modulate pathogenicity.

Authors:  David Jackson; Md Jaber Hossain; Danielle Hickman; Daniel R Perez; Robert A Lamb
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-11       Impact factor: 11.205

9.  Interleukin-1 receptor antagonist attenuates airway hyperresponsiveness following exposure to ozone.

Authors:  Jung-Won Park; Christian Taube; Christina Swasey; Taku Kodama; Anthony Joetham; Annette Balhorn; Katsuyuki Takeda; Nobuaki Miyahara; Corrie B Allen; Azzeddine Dakhama; Soo-Hyun Kim; Charles A Dinarello; Erwin W Gelfand
Journal:  Am J Respir Cell Mol Biol       Date:  2004-01-30       Impact factor: 6.914

10.  A single-amino-acid substitution in the HA protein changes the replication and pathogenicity of the 2009 pandemic A (H1N1) influenza viruses in vitro and in vivo.

Authors:  Lili Xu; Linlin Bao; Qi Lv; Wei Deng; Yila Ma; Fengdi Li; Lingjun Zhan; Hua Zhu; Chunmei Ma; Chuan Qin
Journal:  Virol J       Date:  2010-11-18       Impact factor: 4.099

View more
  10 in total

1.  Naturally occurring mutations in the PA gene are key contributors to increased virulence of pandemic H1N1/09 influenza virus in mice.

Authors:  Yipeng Sun; Qi Xu; Ye Shen; Linqing Liu; Kai Wei; Honglei Sun; Juan Pu; Kin-Chow Chang; Jinhua Liu
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

Review 2.  Dissecting influenza virus pathogenesis uncovers a novel chemical approach to combat the infection.

Authors:  Michael B A Oldstone; John R Teijaro; Kevin B Walsh; Hugh Rosen
Journal:  Virology       Date:  2013-01-05       Impact factor: 3.616

3.  Human Dendritic Cell Response Signatures Distinguish 1918, Pandemic, and Seasonal H1N1 Influenza Viruses.

Authors:  Boris M Hartmann; Juilee Thakar; Randy A Albrecht; Stefan Avey; Elena Zaslavsky; Nada Marjanovic; Maria Chikina; Miguel Fribourg; Fernand Hayot; Mirco Schmolke; Hailong Meng; James Wetmur; Adolfo García-Sastre; Steven H Kleinstein; Stuart C Sealfon
Journal:  J Virol       Date:  2015-07-29       Impact factor: 5.103

4.  Disease severity is associated with differential gene expression at the early and late phases of infection in nonhuman primates infected with different H5N1 highly pathogenic avian influenza viruses.

Authors:  Yukiko Muramoto; Jason E Shoemaker; Mai Quynh Le; Yasushi Itoh; Daisuke Tamura; Yuko Sakai-Tagawa; Hirotaka Imai; Ryuta Uraki; Ryo Takano; Eiryo Kawakami; Mutsumi Ito; Kiyoko Okamoto; Hirohito Ishigaki; Hitomi Mimuro; Chihiro Sasakawa; Yukiko Matsuoka; Takeshi Noda; Satoshi Fukuyama; Kazumasa Ogasawara; Hiroaki Kitano; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

5.  Synergy between the classical and alternative pathways of complement is essential for conferring effective protection against the pandemic influenza A(H1N1) 2009 virus infection.

Authors:  Ajitanuj Rattan; Shailesh D Pawar; Renuka Nawadkar; Neeraja Kulkarni; Girdhari Lal; Jayati Mullick; Arvind Sahu
Journal:  PLoS Pathog       Date:  2017-03-16       Impact factor: 6.823

6.  Identification and in vivo Efficacy Assessment of Approved Orally Bioavailable Human Host Protein-Targeting Drugs With Broad Anti-influenza A Activity.

Authors:  Theresa Enkirch; Svenja Sauber; Danielle E Anderson; Esther S Gan; Dimitar Kenanov; Sebastian Maurer-Stroh; Veronika von Messling
Journal:  Front Immunol       Date:  2019-06-05       Impact factor: 7.561

7.  Comparison of the Pathogenicity in Mice of A(H1N1)pdm09 Viruses Isolated between 2009 and 2015 in Japan.

Authors:  Hiromichi Mitake; Atsuhiro Yasuhara; Tiago J S Lopes; Yuko Tagawa-Sakai; Kohei Shimizu; Hiroki Ozawa; Chiharu Kawakami; Saeko Morikawa; Norio Sugaya; Tokiko Watanabe; Yoshihiro Kawaoka
Journal:  Viruses       Date:  2020-01-29       Impact factor: 5.048

8.  Modified vaccinia virus Ankara encoding influenza virus hemagglutinin induces heterosubtypic immunity in macaques.

Authors:  Kelsey R Florek; Jason T Weinfurter; Sinthujan Jegaskanda; Joseph N Brewoo; Tim D Powell; Ginger R Young; Subash C Das; Masato Hatta; Karl W Broman; Olav Hungnes; Susanne G Dudman; Yoshihiro Kawaoka; Stephen J Kent; Dan T Stinchcomb; Jorge E Osorio; Thomas C Friedrich
Journal:  J Virol       Date:  2014-09-10       Impact factor: 5.103

9.  Establishment of MDCK Stable Cell Lines Expressing TMPRSS2 and MSPL and Their Applications in Propagating Influenza Vaccine Viruses in Absence of Exogenous Trypsin.

Authors:  Zhiyuan Wen; Chao Wu; Weiye Chen; Xianying Zeng; Jianzhong Shi; Jinying Ge; Hualan Chen; Zhigao Bu
Journal:  Biotechnol Res Int       Date:  2015-03-30

10.  The Marmoset as an Animal Model of Influenza: Infection With A(H1N1)pdm09 and Highly Pathogenic A(H5N1) Viruses via the Conventional or Tracheal Spray Route.

Authors:  Kiyoko Iwatsuki-Horimoto; Noriko Nakajima; Maki Kiso; Kenta Takahashi; Mutsumi Ito; Takashi Inoue; Machiko Horiuchi; Norio Okahara; Erika Sasaki; Hideki Hasegawa; Yoshihiro Kawaoka
Journal:  Front Microbiol       Date:  2018-05-09       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.